Preventice: Boston Scientific to buy Preventice in deal worth up to $1.225 Billion

Medical device maker Boston Scientific (BSX) - Get Report announced that it has agreed to acquire Preventice Solutions, a privately-held company that offers a portfolio of mobile cardiac health services, for up to $1.225 billion. The deal features a cash payment of $925 million up front and an additional $300 mullion in a potential commercial [...]The post Boston Scientific to buy Preventice in deal worth up to $1.225 Billion appeared first on Medical Buyer.